Moreover, there are many studies recognizing IL6 as a key cytokine in progressive breast cancer, confirming that high levels of IL6 are related to poor breast cancer prognoses and showcasing its therapeutic significance in treating cancer patients [18, 19, 70]. This evidence concerns the gene IL6 and breast carcinoma.